UConn Health
Expert Discusses First and Only Drug Approved for Progressive Multiple Sclerosis
Dr. Matthew Tremblay, who specializes in the care of patients with multiple sclerosis at UConn Health, discusses a new drug just approved by the FDA.
Mark of Malignancy Identified in Prostate Cancer
Researchers at UConn Health have identified a protein that appears to indicate how aggressive a prostate cancer will be, potentially leading the way to new treatments.
Sick Stem Cells Point to Better MS Drugs
UConn Health researchers think they know why a particularly aggressive form of multiple sclerosis has so far proved unresponsive to drug treatments. They hope this knowledge will help develop better treatments.
Scientists Pave Path for Tackling Rare Cancers Without Effective Treatments
Genomic analysis is opening the doors to diseases that could never have been understood through traditional biomedical research because there simply aren’t enough patients to observe.
Colonoscopy Just the Start in Preventing Colorectal Cancer
Research at UConn Health has uncovered predictors of the development of polyps that can lead to colorectal cancer.
UConn Pilots New Measure of How Fast You Walk
A sudden slowdown in gait speed signals a senior's health is in decline.
On Match Day, Second Sister Wins First Choice Placement
Sibling rivalry now a thing of the past, Neda Shahriari – the second sister to choose a career in dermatology – waits anxiously to find out where she will do her training.
Medical Students Find their Match
Friday was Match Day for UConn medical students – the day they find out where they will pursue their residencies for the next three to six years.
The Healing Power of Fat
A patient at UConn Health has his voice restored with help from an unlikely source: his body's fat cells.
I’ve Heard of it, But What Exactly is Epilepsy?
With UConn Health poised to open a new Epilepsy Monitoring Unit in April, the head of the neurology department discusses this common seizure condition.